當(dāng)前位置：首頁(yè) JCRQ1 期刊介紹(非官網(wǎng))

Clinical Reviews In Allergy & ImmunologySCIE

國(guó)際簡(jiǎn)稱：CLIN REV ALLERG IMMU 參考譯名：過(guò)敏和免疫學(xué)臨床評(píng)論

中科院分區(qū)
2區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：1080-0549; E-ISSN：1559-0267; 是否OA：未開(kāi)放; 是否預(yù)警：否; TOP期刊：是

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Springer US; 出版語(yǔ)言：English; 出版周期：Bimonthly; 出版年份：1983; 研究方向：醫(yī)學(xué)-過(guò)敏

評(píng)價(jià)信息：: 影響因子：8.4; H-index：67; CiteScore指數(shù)：22.3; SJR指數(shù)：2.195; SNIP指數(shù)：2.787

發(fā)文數(shù)據(jù)：: Gold OA文章占比：29.93%; 研究類文章占比：5.56%; 年發(fā)文量：18; 自引率：0.0109...; 開(kāi)源占比：0.219; 出版撤稿占比：0; 出版國(guó)人文章占比：0.11; OA被引用占比：0.1125...

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Clinical Reviews In Allergy & Immunology期刊介紹

This journal publishes scholarly reviews and experimental papers that address the state of the art in the management of allergic and immunologic diseases and in particular place newly available data into perspective. Each issue of the journal is devoted to a single theme of critical importance to allergists and immunologists, with the goal of providing a comprehensive treatment of the subject that will benefit a wide readership. Readers will find the journal of value in elucidating the impact of novel data on clinical management against the background of advances such as the development of standardized protocols for allergy skin testing and challenge procedures and improved understanding of cell biology. The ultimate objective is to help improve the care and management of patients with immune-mediated disease.

期刊簡(jiǎn)介Clinical Reviews In Allergy & Immunology期刊介紹

《Clinical Reviews In Allergy & Immunology》自1983出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：較慢,6-12周
國(guó)際TOP期刊
醫(yī)學(xué)
ALLERGY
SCIE
中科院2區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Clinical Reviews In Allergy & Immunology Cite Score數(shù)據(jù)

CiteScore：22.3
SJR：2.195
SNIP：2.787

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Immunology and Allergy	Q1	15 / 233	93%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Clinical Reviews In Allergy & Immunology 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：是 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	2區(qū)	ALLERGY 過(guò)敏 IMMUNOLOGY 免疫學(xué)	1區(qū) 2區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Clinical Reviews In Allergy & Immunology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ALLERGY	SCIE	Q1	3 / 39	93.6%
學(xué)科：IMMUNOLOGY	SCIE	Q1	16 / 181	91.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ALLERGY	SCIE	Q1	3 / 39	93.59%
學(xué)科：IMMUNOLOGY	SCIE	Q1	18 / 181	90.33%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
USA108
CHINA MAINLAND35
Italy33
France19
Iran16
Switzerland14
England8
GERMANY (FED REP GER)7
Netherlands7
Brazil6

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Public Health Measures and the Control of COVID-19 in China
Author: Cheng, Zhangkai Jason; Zhan, Zhiqing; Xue, Mingshan; Zheng, Peiyan; Lyu, Jiali; Ma, Jing; Zhang, Xiaohua Douglas; Luo, Wenting; Huang, Huimin; Zhang, Yong; Wang, Hongman; Zhong, Nanshan; Sun, Baoqing

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. 64, Issue 1, pp. 1-16. DOI: 10.1007/s12016-021-08900-2
2、Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis
Author: Zhuang, Xiufen; Hu, Xiao; Zhang, Shuren; Li, Xingmin; Yuan, Xiaoying; Wu, Yanhong

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. 64, Issue 3, pp. 284-320. DOI: 10.1007/s12016-021-08892-z
3、Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
Author: Cheng, Zhangkai J.; Li, Bizhou; Zhan, Zhiqing; Zhao, Zifan; Xue, Mingshan; Zheng, Peiyan; Lyu, Jiali; Hu, Chundi; He, Jianxing; Chen, Ruchong; Sun, Baoqing

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. 64, Issue 1, pp. 17-32. DOI: 10.1007/s12016-021-08912-y
4、Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis
Author: Qin, Rundong; He, Li; Yang, Zhaowei; Jia, Nan; Chen, Ruchong; Xie, Jiaxing; Fu, Wanyi; Chen, Hao; Lin, Xinliu; Huang, Renbin; Luo, Tian; Liu, Yukai; Yao, Siyang; Jiang, Mei; Li, Jing

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. 64, Issue 1, pp. 33-65. DOI: 10.1007/s12016-021-08908-8
5、Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Author: Zhang, Jin-jin; Dong, Xiang; Liu, Guang-hui; Gao, Ya-dong

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. 64, Issue 1, pp. 90-107. DOI: 10.1007/s12016-022-08921-5
6、The Evolving Landscape of Fecal Microbial Transplantation
Author: Shao, Tihong; Hsu, Ronald; Hacein-Bey, Camelia; Zhang, Weici; Gao, Lixia; Kurth, Mark J.; Zhao, Huanhuan; Shuai, Zongwen; Leung, Patrick S. C.

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12016-023-08958-0
7、Impact of Air Pollution on Atopic Dermatitis: A Comprehensive Review
Author: Pan, Zhouxian; Dai, Yimin; Akar-Ghibril, Nicole; Simpson, Jessica; Ren, Huali; Zhang, Lishan; Hou, Yibo; Wen, Xueyi; Chang, Christopher; Tang, Rui; Sun, Jin-Lyu

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12016-022-08957-7
8、Single-Cell Analysis of Patients with Axial Spondyloarthritis After Anti-TNF alpha Treatment: Experimental Data and Review of the Literature
Author: Zhao, Zhi-Bin; Bian, Zhen-Hua; Lin, Zhang-Mei; Wu, Shu-Fan; Long, Jie; Cui, Yang; Li, Yang; Li, Wende; Sun, Er-Wei; Lian, Zhe-Xiong; He, Yi

Journal: CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12016-023-08959-z